Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to one class of notes issued by the reset of Hildene TruPS Securitization 2018-1, Ltd. (HITR 2018-1), a securitization backed by a portfolio of bank and insurance TruPs CDO assets. HITR 2018-1 is expected to have a performing collateral par value of $343.76 million and liabilities of $325.0 million from 62 obligors (72 assets). The deal maturity is on 10 October 2038. If all classes of notes can be repaid, the transaction is expected t...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) on June 1, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 28, 2026 (the “2026 Form 10-Q”) with the Securities and Exchange Commissi...

LOS ANGELES--(BUSINESS WIRE)--The TCW Group, a leading global investment firm, announced today that the TCW Strategic Income Fund, Inc. (NYSE: TSI) has declared a monthly distribution of $0.0283 per share payable on June 30, 2026, to shareholders of record on June 15, 2026. Distributions are based on the Fund’s accumulated net investment income and/or other sources for the applicable month. The Directors continue to monitor conditions and circumstances relating to the distribution of dividends...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing its monthly report for the period ended May 31, 2026. An aggregate total distribution of $6.9 million or $0.091522 per trust certificate will be paid on June 10, 2026, to certificateholders of record as of June 9, 2026. Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can...

NEW YORK--(BUSINESS WIRE)--Riskified Ltd. (NYSE: RSKD) (the “Company”), a leader in ecommerce fraud and risk intelligence, today announced that on June 4, 2026, the Company's Board of Directors (the “Board”) authorized the repurchase of up to $75 million of the Company’s Class A ordinary shares, subject to the completion of required Israeli regulatory procedures. This authorization is in addition to the Company’s existing $375 million share repurchase authorizations in the aggregate, of which a...

DALLAS--(BUSINESS WIRE)--The second paragraph in the "A unified foundation for AI at work" section of the release dated March 17, 2026, has been removed. The updated release reads: ISLAND MAKES AI WORK FOR THE ENTERPRISE Island delivers new AI security, agentic controls, and AI publishing capabilities to enable enterprise AI at scale Island, the platform for enterprise work, rolled out new Enterprise AI offerings today to help organizations adopt and scale AI with the visibility and control ent...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed at the Company's website at www.sinovac.com.cn or www.sinovac.com and at the SEC’s website www.sec.gov. The Company also...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Tempus Founder and CEO Eric Lefkofsky will participate in a fireside chat at 2:00 p.m. ET on Monday, June 8. A live webcast of the conversation will be available here. About Tempus Tempus is a technology company advancing precision medicine through the practi...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva Technologies, Inc. (“Aeva” or the “Company”, Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced the closing of its follow-on public offering with gross proceeds of $115.0 million, before underwriting discounts and commissions and estimated offering expenses. The company sold 5,168,539 shares of its common stock at a price to the public of $22.25 per share, which include 674,157 shares of common stock issued upo...

SHANGHAI--(BUSINESS WIRE)--CicadaBio today announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion protein, were shared during an oral presentation at the American Diabetes Association (ADA) Scientific Sessions 2026. The data demonstrated robust weight reduction, preservation of lean mass, reduced weight regain following treatment discontinuation and the potential for extended dosing intervals. CC-18 is designed to address a growing challenge in...